Cargando…
Current State of Anthrax Vaccines and Key R&D Gaps Moving Forward
A licensed anthrax vaccine has been available for pre-exposure prophylaxis in the United States since 1970, and it was approved for use as a post-exposure prophylaxis, in combination with antibiotic treatment, in 2015. A variety of other vaccines are available in other nations, approved under variou...
Autores principales: | Clark, Adam, Wolfe, Daniel N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285291/ https://www.ncbi.nlm.nih.gov/pubmed/32365729 http://dx.doi.org/10.3390/microorganisms8050651 |
Ejemplares similares
-
Moving forward with an imperfect vaccine
por: Pezzoli, Lorenzo, et al.
Publicado: (2021) -
MERS-CoV: address the knowledge gaps to move forward
por: The Lancet
Publicado: (2014) -
Burkholderia vaccines: are we moving forward?
por: Choh, Leang-Chung, et al.
Publicado: (2013) -
Lupus Nephritis: Current Perspectives and Moving Forward
por: Lichtnekert, Julia, et al.
Publicado: (2022) -
Anthrax Vaccines
por: Splino, Miroslav, et al.
Publicado: (2005)